PMID 26643954
Listen to your body If your body is telling you it doesn't want alcohol anymore, that's worth paying attention to
I n the future, innovation will likely focus on five key areas: long-acting formulations, oral delivery methods, multi-target approaches, combination therapies, and expanding the range of indications
The study looked at whether a combination of cardiovascular outcomes (heart attack, stroke, cardiac death, mini-stroke, urgent heart surgery for coronary disease) were more common in the allopurinol or the febuxostat group
Clearly disclaim human use unless within an approved clinical trial
This means the calorie deficit that once led to consistent weight loss may no longer be as effective, causing you to hit a weight loss plateau